Jump to content

Trigeminal nerve stimulation: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
corrected refs and catagories
fixed reference
Line 1: Line 1:
Trigeminal nerve stimulation (TNS) or external Trigenimal nerve stimulation (eTNS) is a non-medication therapy option for the treatment of [[Attention deficit hyperactivity disorder]] approved in the [[United States]] by the [[FDA]] for the treatment of ADHD in children ages 7-12.<ref>{{Cite web |last=Commissioner |first=Office of the |date=2020-03-24 |title=FDA permits marketing of first medical device for treatment of ADHD |url=https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-first-medical-device-treatment-adhd |access-date=2024-01-10 |website=FDA |language=en}}</ref><ref>{{PMID|30768389}}</ref><ref>{{Cite web |url=https://www.apa.org/monitor/2019/07-08/adhd-children |access-date=2024-01-10 |website=www.apa.org}}</ref> It is also used [[off-label]] to treat ADHD in adults.
Trigeminal nerve stimulation (TNS) or external Trigenimal nerve stimulation (eTNS) is a non-invasive, non-medication therapy option for the treatment of [[Attention deficit hyperactivity disorder]] approved in the [[United States]] by the [[FDA]] for the treatment of ADHD in children ages 7-12.<ref>{{Cite web |last=Commissioner |first=Office of the |date=2020-03-24 |title=FDA permits marketing of first medical device for treatment of ADHD |url=https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-first-medical-device-treatment-adhd |access-date=2024-01-10 |website=FDA |language=en}}</ref><ref>{{PMID|30768393}}</ref><ref>{{Cite web |url=https://www.apa.org/monitor/2019/07-08/adhd-children |access-date=2024-01-10 |website=www.apa.org}}</ref> It is also used [[off-label]] to treat ADHD in adults.


External trigeminal nerve stimulation (eTNS) is similar to [[transcutaneous electrical nerve stimulation]] (TENS), a treatment for chronic [[pain]]. A small device supplies electricity to electrodes that are placed on the skin. The device is able to modulate the intensity and frequency of electrical impulses delivered to the nerve endings in the skin.
External trigeminal nerve stimulation (eTNS) is similar to [[transcutaneous electrical nerve stimulation]] (TENS), a treatment for chronic [[pain]]. A small device supplies electricity to electrodes that are placed on the skin. The device is able to modulate the intensity and frequency of electrical impulses delivered to the nerve endings in the skin.

Revision as of 03:16, 10 January 2024

Trigeminal nerve stimulation (TNS) or external Trigenimal nerve stimulation (eTNS) is a non-invasive, non-medication therapy option for the treatment of Attention deficit hyperactivity disorder approved in the United States by the FDA for the treatment of ADHD in children ages 7-12.[1][2][3] It is also used off-label to treat ADHD in adults.

External trigeminal nerve stimulation (eTNS) is similar to transcutaneous electrical nerve stimulation (TENS), a treatment for chronic pain. A small device supplies electricity to electrodes that are placed on the skin. The device is able to modulate the intensity and frequency of electrical impulses delivered to the nerve endings in the skin.

There is ongoing investigation and research into the use of trigeminal nerve stimulation to treat other psychiatric disorders, such as depression and PTSD.[4]

References

  1. ^ Commissioner, Office of the (2020-03-24). "FDA permits marketing of first medical device for treatment of ADHD". FDA. Retrieved 2024-01-10.
  2. ^ PMID 30768393
  3. ^ www.apa.org https://www.apa.org/monitor/2019/07-08/adhd-children. Retrieved 2024-01-10. {{cite web}}: Missing or empty |title= (help)
  4. ^ PMID 26818103